# FDA Inspection 620930 - Polypeptide Laboratories France - September 16, 2009

Source: https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-france/363049b8-dd51-4d85-88cb-dc85984e80d3
Source feed: FDA_Inspections

> FDA Inspection 620930 for Polypeptide Laboratories France on September 16, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 620930
- Company Name: Polypeptide Laboratories France
- Inspection Date: 2009-09-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1280973 - 2024-07-04](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-france/e18fc9be-2980-4e11-a3ef-554bf9e25eeb)
- [FDA Inspection 1107059 - 2019-09-12](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-france/f1607905-c41c-4439-a7e1-b5aa4865da15)
- [FDA Inspection 884800 - 2014-05-23](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-france/5a06c01c-8c46-4860-8434-a18449de5710)

Company: https://www.keypedia.com/companies/polypeptide-laboratories-france/a335ec84-dffa-4fa6-91ef-e7597d35c228

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c